Why AI/ML Could be a Game-Changer for Enterprises.

Host: Welcome to a new episode of the Future Powered Podcast! Today, we're thrilled to have with us Mr. Luca Emili, the CEO of InSilico Trials. InSilico Trials is revolutionizing the pharmaceutical industry with a unique simulation platform that reduces R&D costs and accelerates drug approvals. Using the latest technologies like AI and machine learning, their approach is truly cutting-edge. Thank you, Luca, for joining us today. Luca: Thank you, Suresh, and hello to everyone listening. I'm excited to share the journey of how we've leveraged deep tech to innovate drug development. Our mission is to provide researchers and scientists with a technological edge, creating value and a competitive advantage in their fight against disease. Host: Absolutely. It's inspiring to hear about the impact you're making. Let's dive into your journey. Can you tell us how InSilico Trials came to be? Luca: Of course! InSilico Trials started its market journey in 2022, but th...

Paperwork is daunting and time-consuming, often leaving one with the fear of human errors. However, evolving technologies can solve this issue through their extensive capacities. One such advancement is the emergence of Optical Character Recognition (OCR), which is transforming various sectors through text recognition abilities. OCR is a technology that converts text images into machine-readable text format. Businesses use OCR to read and capture data from receipts or extract data from documents. OCR has long been significant in digitizing printed and handwritten documents to make information extraction easier and more efficient. However, with the advent of technological reforms in the digitized world, especially with AI, the introduction of generative AI (GenAI) is solving the limitations seen in the traditional OCR. Explore how GenAI is reshaping OCR technology and its myriad benefits for document processing. Enhancing OCR with Generative AI Improved Accuracy and Precision GenAI alg...